Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

TerminatedNot Applicable

NCT00467987

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors…

United States47 participantsStarted 2007-06-01

Treatment: androgel, placebo